UPDATE: Morgan Stanley Reiterates Overweight Rating, Raises PT on Actavis plc as M&A Could Offer Additional Upside


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


In a report published Thursday, Morgan Stanley analyst David Risinger reiterated an Overweight rating on

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Actavis plc (NYSE: ACT), and raised the price target from $246.00 to $266.00.In the report, Morgan Stanley noted, “We believe more large-cap Value and GARP fund managers will come to appreciate Actavis. ACT is now hitting mega-cap radar screens since its mkt cap has stepped up from $18B in Aug. '13 to $60B today. We think ACT is an attractive alternative to large-cap pharma because it trades at a discount on 2015E P/E (14x vs. 17x) and senior mgmt. are astute leaders with a sense of urgency to create extra value via M&A.”Actavis plc closed on Wednesday at $228.55.
Posted In: Analyst ColorPrice TargetAnalyst RatingsDavid RisingerMorgan Stanley